Manu Rajachandran, MD
Interventional Cardiology · El Paso, TXNPI 1639132558
Payments from drug & device makers
Across 59 payments — averaging $406.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$21K
- Philips North America LLC$452
- Inari Medical, Inc.$435
- Penumbra, Inc.$431
- Edwards Lifesciences$381
- E.r. Squibb & Sons, L.L.C.$229
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,098100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 4 | $20,882 |
| Philips North America LLC | 7 | $452 |
| Inari Medical, Inc. | 4 | $435 |
| Penumbra, Inc. | 4 | $431 |
| Edwards Lifesciences | 3 | $381 |
| E.r. Squibb & Sons, L.L.C. | 8 | $229 |
| Stryker | 2 | $224 |
| Medtronic | 9 | $213 |
| Shockwave Medical, Inc | 2 | $179 |
| Heartflow, Inc. | 1 | $122 |
| Recor Medical Inc | 1 | $97 |
| Abbott | 2 | $79 |
| Abiomed | 1 | $53 |
| Bard Peripheral Vascular, Inc. | 2 | $33 |
| Asahi Intecc USA, Inc. | 1 | $33 |
| Boston Scientific | 2 | $32 |
| AstraZeneca | 2 | $24 |
| Cvrx, Inc. | 1 | $23 |
| Medline Industries LP | 1 | $23 |
| Cook Medical LLC | 1 | $18 |
| Pfizer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,981 in reported general payments places this provider in the 70th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in El Paso
- Mohammad RajaEl Paso$319K
- Robert StolerDallas$8.2M
- James ChoiDallas$5.2M
- Srinivasa PotluriPlano$5.1M
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
- Ira LieberKingwood$3.3M
- Cara Ann EastDallas$3M
- Abhijeet DhobleHouston$2.7M
- Jeffrey CarrTyler$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.